Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Management of patients with long-term inhibitors: is immune tolerance an underestimated life-long solution?

Di Minno G, Coppola A.

Haemophilia. 2013 Jan;19 Suppl 1:18-23. doi: 10.1111/hae.12052.

PMID:
23278996
[PubMed - indexed for MEDLINE]
2.

Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence-based approaches.

Coppola A, Di Minno MN, Santagostino E.

Br J Haematol. 2010 Sep;150(5):515-28. doi: 10.1111/j.1365-2141.2010.08263.x. Epub 2010 Jun 22. Review.

PMID:
20573153
[PubMed - indexed for MEDLINE]
3.

Inhibitors in haemophilia A: current management and open issues.

Haya S, Moret A, Cid AR, Cortina V, Casaña P, Cabrera N, Aznar JA.

Haemophilia. 2007 Dec;13 Suppl 5:52-60. doi: 10.1111/j.1365-2516.2007.01574.x. Review.

PMID:
18078398
[PubMed - indexed for MEDLINE]
4.

The immune tolerance induction (ITI) dose debate: does the International ITI Study provide a clearer picture?

Ettingshausen CE, Kreuz W.

Haemophilia. 2013 Jan;19 Suppl 1:12-7. doi: 10.1111/hae.12051. Review.

PMID:
23278995
[PubMed - indexed for MEDLINE]
5.

Immune tolerance induction in patients with hemophilia A.

Astermark J.

Thromb Res. 2011 Jan;127 Suppl 1:S6-9. doi: 10.1016/j.thromres.2010.10.006. Epub 2010 Nov 5.

PMID:
21056905
[PubMed - indexed for MEDLINE]
6.

Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors.

Unuvar A, Warrier I, Lusher JM.

Haemophilia. 2000 May;6(3):150-7.

PMID:
10792472
[PubMed - indexed for MEDLINE]
7.

More than a decade of international experience with a pdFVIII/VWF concentrate in immune tolerance.

Santagostino E.

Haemophilia. 2013 Jan;19 Suppl 1:8-11. doi: 10.1111/hae.12050. Review.

PMID:
23278994
[PubMed - indexed for MEDLINE]
8.

Economic modelling of different treatment strategies for haemophilia A with high-responding inhibitors.

Knight C, Paisley S, Wight J, Jones ML.

Haemophilia. 2003 Jul;9(4):521-40. Review.

PMID:
12828681
[PubMed - indexed for MEDLINE]
9.

Late immune tolerance induction in haemophilia A patients.

Meeks SL, Chapman RL, Kempton C, Dunn AL.

Haemophilia. 2013 May;19(3):445-8. doi: 10.1111/hae.12077. Epub 2013 Jan 7.

PMID:
23294063
[PubMed - indexed for MEDLINE]
10.

How I treat inhibitors in haemophilia.

Makris M, Hay CR, Gringeri A, D'Oiron R.

Haemophilia. 2012 Jul;18 Suppl 4:48-53. doi: 10.1111/j.1365-2516.2012.02829.x.

PMID:
22726083
[PubMed - indexed for MEDLINE]
11.

Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units.

Ter Avest PC, Fischer K, Gouw SC, Van Dijk K, Mauser-Bunschoten EP.

Haemophilia. 2010 May;16(102):71-9. doi: 10.1111/j.1365-2516.2010.02225.x.

PMID:
20536988
[PubMed - indexed for MEDLINE]
12.

Forum on: the role of recombinant factor VIII in children with severe haemophilia A.

Franchini M, Coppola A, Molinari AC, Santoro C, Schinco P, Speciale V, Tagliaferri A.

Haemophilia. 2009 Mar;15(2):578-86. doi: 10.1111/j.1365-2516.2008.01975.x. Epub 2009 Feb 1.

PMID:
19187188
[PubMed - indexed for MEDLINE]
13.

Immune tolerance induction for the eradication of inhibitors in patients with hemophilia A.

Kruse-Jarres R, Barnett B, Leissinger C.

Expert Opin Biol Ther. 2008 Dec;8(12):1885-96. doi: 10.1517/14712590802515537 . Review.

PMID:
18990076
[PubMed - indexed for MEDLINE]
14.

Application of current knowledge to the management of bleeding events during immune tolerance induction.

Di Paola J, Aledort L, Britton H, Carcao M, Grabowski E, Hutter J, Journeycake J, Kempton C, Leissinger C.

Haemophilia. 2006 Nov;12(6):591-7. Review.

PMID:
17083508
[PubMed - indexed for MEDLINE]
15.

Epidemiology of inhibitors and current treatment strategies.

Kreuz W, Ettingshausen CE, Auerswald G, Saguer IM, Becker S, Funk M, Heller C, Klarmann D, Klingebiel T; GTH PUP Study Group.

Haematologica. 2003 Jun;88(6):EREP04. Review.

PMID:
12826530
[PubMed - indexed for MEDLINE]
16.

Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaper.

Colowick AB, Bohn RL, Avorn J, Ewenstein BM.

Blood. 2000 Sep 1;96(5):1698-702.

PMID:
10961866
[PubMed - indexed for MEDLINE]
Free Article
17.

Use of Haemate(®) P as immune tolerance induction in patients with severe haemophilia A who failed previous induction attempts: a multicentre observational study.

Rothschild C, D'Oiron R, Borel-Derlon A, Gruel Y, Navarro R, Negrier C.

Haemophilia. 2013 Mar;19(2):281-6. doi: 10.1111/hae.12018. Epub 2012 Oct 8.

PMID:
23038998
[PubMed - indexed for MEDLINE]
18.

New protocol for immune tolerance induction in acquired hemophilia.

Nemes L, Pitlik E.

Haematologica. 2000 Oct;85(10 Suppl):64-8.

PMID:
11187874
[PubMed - indexed for MEDLINE]
19.

VWF/FVIII concentrates in high-risk immunotolerance: the RESIST study.

Gringeri A.

Haemophilia. 2007 Dec;13 Suppl 5:73-7. doi: 10.1111/j.1365-2516.2007.01579.x.

PMID:
18078402
[PubMed - indexed for MEDLINE]
20.

The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.

Greninger DA, Saint-Remy JM, Jacquemin M, Benhida A, DiMichele DM.

Haemophilia. 2008 Mar;14(2):295-302. Epub 2007 Dec 12.

PMID:
18081826
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk